Numa Health

Numa Health, a French biotech firm established in 2019, operates at the intersection of predictive and preventive medicine. The company was co-founded by Thomas Schmit, a former high-level athlete with a background in integrative physiology, and Dr. Kamyar Hedayat, a pediatric intensive care specialist with extensive experience in integrative medicine. Schmit's journey began with developing wellness programs for the Accor Group to prevent musculoskeletal disorders and burnout, while Dr. Hedayat previously directed the intensive care unit and integrative medicine department at Sutton Children's Hospital. Their combined expertise forms the foundation of the company's approach, which is rooted in over 40 years of clinical research.

The firm develops custom digital health tools that integrate into the care pathways of its B2B clients, which include pharmaceutical laboratories, medical biology labs, healthcare institutions, and insurance companies. Numa Health's core offering is a platform that analyzes multi-source data, primarily from blood tests and lifestyle questionnaires, to provide optimized summaries for medical decision-making. Through its "Health Pilot" application, the technology delivers a personalized health score and actionable recommendations, with a significant focus on identifying and managing physiological stress. This enables clients to offer enriched, individualized services, optimize consultation times, and personalize patient recommendations.

Numa Health generates revenue through its tailored solutions for corporate clients, including companies aiming to educate employees on stress impacts, insurance providers offering preventive care to their members, and sports clubs seeking to enhance athlete performance. The company has secured significant funding to support its growth, including a €1.3 million seed round in July 2020 and a subsequent €4 million ($4.39M) Series A round in June 2023. Key investors include Bpifrance, Groupe Inovie, Groupe Pasteur Mutualité, and RGREEN INVEST. This strategic backing aims to facilitate international expansion and broaden the deployment of its services, notably making its health assessment tool available to the 160,000 members of Groupe Pasteur Mutualité.

Keywords: predictive medicine, preventive healthcare, digital health platform, biotech, health data analysis, physiological stress, blood test interpretation, personalized health, integrative medicine, corporate wellness, insurance health solutions, pharmaceutical technology, medical decision support, Thomas Schmit, Kamyar Hedayat, Health Pilot, B2B healthtech, medical biology, care pathway optimization, venture capital-backed